profit from every SGD 100 of sales.
SGD 0SGD 100
Raffles Medical Group
SGD 0.85+0.59% today
-15.8% since Dec 18, 25
1-year low SGD 0.811-year high SGD 1.07
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average.
0%20% a year
You pay SGD 22.11 for every SGD 1 of profit it makes in a year.
CheapExpensive
It holds more cash than debt.
No debt5 years
Raffles Medical Group vs. similar companies
Raffles Medical Group grows the slowest of these 5 and is priced in the middle for its profits.
| Company | Profit from SGD 100 of sales | Sales growth a year | Price per SGD 1 of profit |
|---|---|---|---|
| Raffles Medical Group | 22.1× · Fair price | ||
 HCA Healthcare | 15.4× · Fair price | ||
 Fresenius SE & Co. KGaA | 23.7× · Fair price | ||
 IHH Healthcare Berhad | 33.3× · Expensive | ||
 Rede D'Or São Luiz | 15.8× · Fair price |
AI analysis
An AI analyst reads Raffles Medical Group's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisNo annual statements on file yet.
Valuation
- 22.1×
- –
- –
- 1.6×
- 2.0×
- 17.1×
- –
- 5.9%
- 4.5%
- –
Profitability
- 65.0%
- 11.7%
- 9.2%
- –
- 7.1%
- 9.5%
- –
- –
- –
- –
Growth
- −2.4%
- −34.0%
- –
- –
- −0.3%
Financial health
- -1.6×
- 0.08
- –
- 23.9×
- 1.31
- –
- –
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Top 43%of 952
Top 44%of 883
Top 38%of 576
Bottom 11%of 870
Top 17%of 985
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
2/7Passes 2 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
64Pass
Benjamin Graham
64Pass
Philip Fisher
50No pass
Peter Lynch
24No pass
Joel Greenblatt
32No pass
Charlie Munger
49No pass
Terry Smith
45No pass
Questions about Raffles Medical Group
Is Raffles Medical Group a good stock to buy?
A solid business at a fair price. 2 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Raffles Medical Group AI analysis
What does Raffles Medical Group do?
Raffles Medical Group Ltd provides private healthcare services in Singapore, Greater China, Vietnam, Cambodia, and Japan. It operates through four segments: Healthcare Services, Hospital Services, Investment Holdings, and Insurance Services. It is in Medical Care Facilities.
Is Raffles Medical Group stock halal?
Yes. Raffles Medical Group passes our halal screen: its business is permitted and its debt is 6% of its market value, under the 30% limit. How we check
Who are Raffles Medical Group's competitors?
The largest listed companies in the same industry are HCA Healthcare, Fresenius SE & Co. KGaA, IHH Healthcare Berhad and Rede D'Or São Luiz. The peers table on this page compares their profit, growth and price with Raffles Medical Group's.
Prices: daily closes to Nov 12, 2026. Fundamentals: company reports via invest-like data.